©The Author(s) 2017. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Cardiol. Jun 26, 2017; 9(6): 553-557
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.553
Published online Jun 26, 2017. doi: 10.4330/wjc.v9.i6.553
Interferon related pericarditis: Review
Kazuaki Nishio, Tsutomu Arase, Hiroko Tada, Hideaki Tachibana, Department of Internal Medicine, Matsui Hospital, Tokyo 145-0082, Japan
Author contributions: Nishio K drafted the manuscript, and assisted with data analysis; Arase T, Tada H and Tachibana H were involved with data collection and data analysis.
Conflict-of-interest statement: The authors of this manuscript having no conflicts of interest to disclose.
Data sharing statement: There is no additional data available.
Correspondence to: Kazuaki Nishio, MD, Department of Internal Medicine, Matsui Hospital, 1-7-10, Ikegami, Ota-ku, Tokyo 145-0082, Japan. kazukun@jg7.so-net.ne.jp
Telephone: +81-3-37521111 Fax: +81-3-37521118
Received: November 11, 2016
Peer-review started: November 13, 2016
First decision: March 8, 2017
Revised: April 21, 2017
Accepted: May 3, 2017
Article in press: May 5, 2017
Published online: June 26, 2017
Processing time: 226 Days and 9.3 Hours
Peer-review started: November 13, 2016
First decision: March 8, 2017
Revised: April 21, 2017
Accepted: May 3, 2017
Article in press: May 5, 2017
Published online: June 26, 2017
Processing time: 226 Days and 9.3 Hours
Core Tip
Core tip: Interferon is considered to be one of the treatments for many diseases. However, interferon therapy is associated with side effects. Recently some reports demonstrated acute pericarditis complicating interferon therapy. Two mechanisms for pericarditis were demonstrated, one is autoimmune included lupus like syndrome and the other is cardio toxicity. However, these two mechanisms are controversial. The aim of this study is to review of “interferon related pericarditis”.